IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Evaluation of the Safety and Efficacy of JointAid Oil in Patients with acute and chronic Musculoskeletal pain: An open label, Non-Comparative, Multicenter clinical trial

Author: DR. DIPAK PATEL, DR. NIRAV JOSHI, DR. PIYUSH THAKKAR
Abstract: The positive effects of topical analgesics have been demonstrated by different clinical studies in the management of certain acute and chronic painful inflammation in musculoskeletal conditions. JointAid Oil which is a polyherbal formulation recommended for the management of painful inflammation in musculoskeletal disorders. For symptomatic management of chronic inflammation in musculoskeletal disorders, various clinical trials had been conducted of JointAid Oil for evaluation of the safety and efficacy. These clinical studies were an open, prospective, noncomparative, proof of concept study. These clinical studies include total of 112 patients, which were suffering from acute and chronic inflammation in musculoskeletal disorders. Patients had been advised to apply topically enough quantity of JointAid Oil, twice daily for a period of 15 days with gentle massage to the affected area. All the patients were evaluated at the beginning and at the end of the study with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) for the muscular pain, joint pain, joint swelling, joint tenderness and early morning joint stiffness along with these, patients had been also checked for local adverse reactions like burning/stinging sensation, irritation, and erythema. This study showed significant reduction in the mean WOMAC score which shows relief in muscular pain, joint pain, joint swelling, joint tenderness, and early morning joint stiffness. Also, during entire period, there have been clinically no significant adverse events and was excellent overall compliance to the treatment of JointAid Oil. Hence, it can be concluded, JointAid Oil is safe and effective in the symptomatic management of chronic inflammation in musculoskeletal disorders.
Keyword: Musculoskeletal, WOMAC, inflammation, morning stiffness
DOI: https://doi.org/10.31838/ijpr/2019.11.01.017
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477